Parvati Sweetners and Power Limited (BOM:541347)
7.48
-0.03 (-0.40%)
At close: Jul 28, 2025
Verve Therapeutics Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2018 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2018 - 2020 |
Cash & Equivalents | 43.4 | 12.87 | 4.07 | 40.01 | 1.8 | Upgrade |
Short-Term Investments | - | 0.32 | - | - | - | Upgrade |
Cash & Short-Term Investments | 43.4 | 13.19 | 4.07 | 40.01 | 1.8 | Upgrade |
Cash Growth | 229.09% | 224.40% | -89.84% | 2124.86% | -93.72% | Upgrade |
Accounts Receivable | 4.01 | 18.04 | 21.9 | 78.72 | 83.01 | Upgrade |
Other Receivables | - | 7.05 | 4.03 | 0.56 | 3.79 | Upgrade |
Receivables | 89.5 | 123.01 | 108.08 | 100.46 | 167.92 | Upgrade |
Inventory | 511.8 | 761.96 | 700.71 | 696.25 | 565.02 | Upgrade |
Prepaid Expenses | - | 0.79 | 0.42 | 0.44 | 0.45 | Upgrade |
Other Current Assets | 87.39 | 38.01 | 39.78 | 39.14 | 30.56 | Upgrade |
Total Current Assets | 732.09 | 936.97 | 853.05 | 876.3 | 765.75 | Upgrade |
Property, Plant & Equipment | 462.56 | 543.45 | 584.21 | 543.98 | 569.62 | Upgrade |
Long-Term Investments | - | - | 0.26 | 0.26 | 0.26 | Upgrade |
Other Long-Term Assets | 4.98 | 4.9 | 4.1 | 0.1 | 0.1 | Upgrade |
Total Assets | 1,401 | 1,687 | 1,643 | 1,631 | 1,550 | Upgrade |
Accounts Payable | 0.05 | 46.49 | 35.87 | 72.95 | 58.77 | Upgrade |
Accrued Expenses | - | 3.47 | 15.66 | 5.02 | 5.03 | Upgrade |
Short-Term Debt | - | 381.73 | 358.24 | 394.94 | 301.63 | Upgrade |
Current Portion of Long-Term Debt | 63 | 21.3 | 27.25 | 45.57 | 30.07 | Upgrade |
Current Portion of Leases | 1.22 | 0 | 0.88 | - | - | Upgrade |
Other Current Liabilities | 27.64 | 38.65 | 21.77 | 46.37 | 39.87 | Upgrade |
Total Current Liabilities | 91.9 | 491.65 | 459.67 | 564.86 | 435.35 | Upgrade |
Long-Term Debt | 226.56 | 111.71 | 131.72 | 335.19 | 488.78 | Upgrade |
Long-Term Leases | 14.59 | 15.81 | 14.06 | - | - | Upgrade |
Long-Term Deferred Tax Liabilities | 49.5 | 54.91 | 39.21 | 39.39 | 43.3 | Upgrade |
Total Liabilities | 382.54 | 674.08 | 644.65 | 939.43 | 967.43 | Upgrade |
Common Stock | 745.72 | 745.72 | 745.72 | 450.9 | 354.27 | Upgrade |
Additional Paid-In Capital | - | 156.72 | 156.72 | 156.72 | 156.72 | Upgrade |
Retained Earnings | - | 110.29 | 96.02 | 83.73 | 71.22 | Upgrade |
Comprehensive Income & Other | 272.85 | - | - | - | - | Upgrade |
Shareholders' Equity | 1,019 | 1,013 | 998.46 | 691.35 | 582.21 | Upgrade |
Total Liabilities & Equity | 1,401 | 1,687 | 1,643 | 1,631 | 1,550 | Upgrade |
Total Debt | 305.37 | 530.55 | 532.14 | 775.7 | 820.47 | Upgrade |
Net Cash (Debt) | -261.97 | -517.37 | -528.07 | -735.69 | -818.67 | Upgrade |
Net Cash Per Share | -1.79 | -3.47 | -3.54 | -8.16 | -11.55 | Upgrade |
Filing Date Shares Outstanding | 153.72 | 149.14 | 149.14 | 90.18 | 70.85 | Upgrade |
Total Common Shares Outstanding | 153.72 | 149.14 | 149.14 | 90.18 | 70.85 | Upgrade |
Working Capital | 640.19 | 445.32 | 393.39 | 311.45 | 330.4 | Upgrade |
Book Value Per Share | 6.63 | 6.79 | 6.69 | 7.67 | 8.22 | Upgrade |
Tangible Book Value | 1,019 | 1,013 | 998.46 | 691.35 | 582.21 | Upgrade |
Tangible Book Value Per Share | 6.63 | 6.79 | 6.69 | 7.67 | 8.22 | Upgrade |
Land | - | 45.87 | 45.87 | 47.77 | 40.28 | Upgrade |
Buildings | - | 136.7 | 136.7 | 117.59 | 117.59 | Upgrade |
Machinery | - | 642.08 | 641.33 | 636.5 | 637.12 | Upgrade |
Construction In Progress | - | 69.82 | 65.27 | 84.03 | 71.21 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.